Estrogen Receptor β-Selective Transcriptional Activity and Recruitment of Coregulators by Phytoestrogens
GPER
Estrogen receptor beta
DOI:
10.1074/jbc.m100953200
Publication Date:
2002-07-26T15:09:24Z
AUTHORS (5)
ABSTRACT
Estrogens used in hormone replacement therapy regimens may increase the risk of developing breast cancer. Paradoxically, high consumption plant-derived phytoestrogens, particularly soybean isoflavones, is associated with a low incidence To explore molecular basis for these potential different clinical outcomes, we investigated whether isoflavones elicit distinct transcriptional actions from estrogens. Our results demonstrate that estrogen 17beta-estradiol effectively triggers activation and repression pathways both receptors (ERs) ERalpha ERbeta. In contrast, (genistein, daidzein, biochanin A) are ERbeta-selective agonists at physiological levels. The mechanism ERbeta selectivity by involves their capacity to create an function-2 surface has greater affinity coregulators than ERalpha. Phytoestrogens act as natural selective receptor modulators effects estrogens selectively recruiting coregulatory proteins trigger pathways.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (64)
CITATIONS (250)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....